European Journal of Pharmaceutics and Biopharmaceutics

EJPB Front Cover

European Journal of Pharmaceutics and Biopharmaceutics is a peer-reviewed scientific journal covering all aspects of pharmaceutics, biopharmaceutics, and drug delivery. Its scope includes the design of drugs, their formulation and delivery, and the study of their pharmacokinetics. The journal aims to publish high-quality research articles, reviews, and short communications in the field of pharmaceutics and biopharmaceutics.

Overview

The European Journal of Pharmaceutics and Biopharmaceutics focuses on the interdisciplinary fields of pharmaceutics and biopharmaceutics, including the development of pharmaceutical technology, nanotechnology in drug delivery, biotechnology, and the application of pharmacokinetics and pharmacodynamics in drug development. It serves as a platform for researchers, academics, and professionals to share their findings and advancements in the pharmaceutical sciences.

Sections

The journal is divided into several sections, each focusing on a specific area within pharmaceutics and biopharmaceutics:

• Drug Delivery and Targeting: This section covers research on novel drug delivery systems, including liposomes, nanoparticles, and polymeric drug delivery systems, and their targeting mechanisms.
• Pharmaceutical Technology: Articles in this section discuss the development and optimization of pharmaceutical processes and the formulation of dosage forms.
• Biopharmaceutics: This area focuses on the study of the interrelationship between the physical/chemical properties of drugs, the dosage forms in which they are given, and the route of administration on the rate and extent of systemic drug absorption.
• Pharmacokinetics/Pharmacodynamics: Research on the absorption, distribution, metabolism, and excretion of drugs, as well as the biochemical and physiological effects of drugs and their mechanisms of action, are covered here.

Editorial Board

The European Journal of Pharmaceutics and Biopharmaceutics is overseen by an international editorial board comprising experts in the field of pharmaceutics, biopharmaceutics, and drug delivery. The board is responsible for maintaining the journal's high standards of scientific quality and integrity.

Submission and Review Process

Manuscripts submitted to the European Journal of Pharmaceutics and Biopharmaceutics undergo a rigorous peer-review process to ensure the publication of high-quality, original, and significant scientific research. The review process is double-blind, meaning that both the reviewers and the authors are anonymized to each other to ensure impartiality.

Impact Factor

The European Journal of Pharmaceutics and Biopharmaceutics has a notable impact factor, reflecting its importance and relevance in the fields of pharmaceutics and biopharmaceutics. The impact factor is a measure of the frequency with which the average article in a journal has been cited in a particular year, serving as an indicator of the journal's influence and prestige.

Access

The journal offers access to its articles through various subscription models, including institutional subscriptions and individual access. Some content may be available open access, providing free, unrestricted access to research findings and facilitating a wider dissemination of information.